Globus Medical Inc (GMED) Stock Price, Quote & News

Company Profile

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; intervention...

Industry: Medical Devices

Sector: Healthcare

Phone: 610 930 1800

Website: www.globusmedical.com

Address:

2560 General Armistead Avenue, Audubon, United States

IndyOne May. 21 at 6:48 PM

$GMED Nice day, looks like a double top now.

0 · Reply

IndyOne May. 21 at 2:04 PM

$GMED Yes. We got cowbell accumulation.

0 · Reply

LiveTradePro May. 20 at 5:53 PM

$GMED Bottom is in https://share.trendspider.com/chart/GMED/6682ed1lml

1 · Reply

NVDAMillionaire May. 20 at 12:26 AM

$GMED Great piece that accurately captures GMED's current position. So if you want to refresh your understanding of GMED or learn about GMED for the first time, this is essential reading. https://everyticker.com/quote/GMED/analysis/globus-medical-s-integrated-musculoskeletal-moat-why-the-nevro-deal-transforms-the-risk-reward-nyse-gmed

0 · Reply

CeaseNDesist May. 19 at 2:19 PM

$GMED green in a sea of red

0 · Reply

IndyOne May. 19 at 10:04 AM

$GMED Needham Raises its Price Target on Globus Medical (GMED) to $117 https://finance.yahoo.com/markets/stocks/articles/needham-raises-price-target-globus-064656298.html

0 · Reply

CapitalMonk May. 12 at 12:10 AM

$GMED Price: $76.68 (-1.63%) Trend: Bullish Market Bias (7D): Bullish Bias 📈 Expected Range: ±1.45% RSI: 18.9 | Momentum: Strong Downside Volume: +75.6% vs avg Volatility: 2.72% Support: $76.52 | Resistance: $97.39 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

MarketBeat May. 10 at 3:12 PM

https://marketbeat.com/a/8646102/ $GMED Globus Medical Q1 Earnings Call Highlights

0 · Reply

StocktwitsEarnings May. 7 at 8:31 PM

$GMED Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.92 up 67.27% YoY • Reported revenue of $759.85M up 27.04% YoY • Globus Medical reaffirms its full-year 2026 revenue guidance of $3.18B to $3.22B and updated non-GAAP diluted EPS guidance to $4.70 to $4.80, raised from $4.40 to $4.50.

0 · Reply

1truth2be3told May. 7 at 8:31 PM

$GMED If I were Globus CEO, this is golden opportunity to buy up ATEC, Pat Miles’ second company as did with his first company, Nuvasive. ATEC is at similar stage as Nuvasive but at much cheaper MC of $1B . Globus paid much more for NuVa.

0 · Reply

Globus Medical Q1 Earnings Call Highlights

2026-05-08T22:34:13.000Z - 21 days ago

Globus Medical price target raised to $117 from $114 at Needham

2026-05-08T12:11:11.000Z - 22 days ago

Globus Medical price target lowered to $103 from $104 at Wells Fargo

2026-05-07T23:09:57.000Z - 22 days ago

Globus Medical reports Q1 EPS $1.12, consensus 92c

2026-05-07T23:09:45.000Z - 22 days ago

Globus Medical raises FY26 EPS view to $4.70-$4.80 from $4.40-$4.50

May 7, 2026, 4:30 PM EDT - 22 days ago

Globus Medical Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 22 days ago

Globus Medical Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 22 days ago

Globus Medical Quarterly report: Q1 2026

May 7, 2026, 4:15 PM EDT - 22 days ago

Globus Medical Reports First Quarter 2026 Results

Apr 24, 2026, 8:00 AM EDT - 5 weeks ago

Globus Medical Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 5 weeks ago

Globus Medical Proxy statement: Proxy filing

Apr 16, 2026, 4:30 PM EDT - 6 weeks ago

Globus Medical Schedules First Quarter Earnings Release and Conference Call

Mar 23, 2026, 5:25 PM EDT - 2 months ago

Globus Medical Announces Board Departure

2026-03-18T10:30:14.000Z - 2 months ago

Globus Medical assumed with an Overweight at Wells Fargo

2026-02-26T11:32:51.000Z - 3 months ago

Globus Medical price target raised to $104 from $98 at Wells Fargo

2026-02-25T14:41:00.000Z - 3 months ago

Globus Medical price target raised to $115 from $105 at Truist

2026-02-25T11:55:49.000Z - 3 months ago

Globus Medical price target raised to $115 from $112 at Canaccord

2026-02-25T10:20:56.000Z - 3 months ago

Globus Medical price target raised to $123 from $118 at Barclays

2026-02-24T21:51:04.000Z - 3 months ago

Globus Medical reports Q4 EPS $1.28, consensus 96c

2026-02-24T21:49:23.000Z - 3 months ago

Globus Medical raises FY26 EPS view to $4.40-$4.50 from $4.30-$4.40

Feb 24, 2026, 4:30 PM EST - 3 months ago

Globus Medical Earnings Call Transcript: Q4 2025

Feb 24, 2026, 4:30 PM EST - 3 months ago

Globus Medical Annual report: Q4 2025

Feb 24, 2026, 4:30 PM EST - 3 months ago

Globus Medical Earnings release: Q4 2025

Feb 24, 2026, 4:15 PM EST - 3 months ago

Globus Medical Reports Fourth Quarter and Full Year 2025 Results

Feb 12, 2026, 4:30 PM EST - 3 months ago

Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

2026-01-30T11:51:18.000Z - 4 months ago

Globus Medical upgraded to Buy from Hold at Needham

2026-01-30T11:50:22.000Z - 4 months ago

Globus Medical upgraded to Buy at Needham on EPS upside potential

2026-01-26T21:40:22.000Z - 4 months ago

Globus Medical initiated with a Buy at TD Cowen

2026-01-09T11:42:17.000Z - 5 months ago

Globus Medical price target raised to $112 from $105 at Canaccord

2026-01-08T12:01:03.000Z - 5 months ago

Globus Medical price target raised to $115 from $90 at Piper Sandler

2026-01-07T21:36:11.000Z - 5 months ago

Globus Medical sees FY25 revenue $2.936B, consensus $2.89B

2026-01-07T21:36:01.000Z - 5 months ago

Globus Medical sees FY26 adjusted EPS $4.30-$4.40, consensus $4.12

Jan 7, 2026, 4:27 PM EST - 5 months ago

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

Nov 7, 2025, 11:08 AM EST - 7 months ago

Globus Medical Stock Soars After Earnings. Where It's Seeing the Strength.

Nov 6, 2025, 4:30 PM EST - 7 months ago

Globus Medical Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 7 months ago

Globus Medical Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 7 months ago

Globus Medical Earnings release: Q3 2025

Nov 6, 2025, 4:15 PM EST - 7 months ago

Globus Medical Reports Third Quarter 2025 Results

Oct 22, 2025, 11:25 AM EDT - 7 months ago

Is Wall Street Underestimating Globus Medical Stock's Potential?

Oct 16, 2025, 4:30 PM EDT - 8 months ago

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

Oct 14, 2025, 4:40 PM EDT - 8 months ago

Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma

Aug 28, 2025, 4:30 PM EDT - 9 months ago

Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.

Aug 7, 2025, 4:30 PM EDT - 10 months ago

Globus Medical Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 10 months ago

Globus Medical Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 10 months ago

Globus Medical Earnings release: Q2 2025

Aug 7, 2025, 4:15 PM EDT - 10 months ago

Globus Medical Reports Second Quarter 2025 Results

Jul 21, 2025, 8:00 AM EDT - 11 months ago

Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results

Jul 17, 2025, 4:30 PM EDT - 11 months ago

Globus Medical Schedules Second Quarter Earnings Release and Conference Call

Jul 15, 2025, 4:15 PM EDT - 11 months ago

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue

May 15, 2025, 4:30 PM EDT - 1 year ago

Globus Medical Announces $500 Million Share Repurchase Program

May 13, 2025, 6:28 PM EDT - 1 year ago

Medical, Inc. Company Investigated by the Portnoy Law Firm

May 8, 2025, 4:30 PM EDT - 1 year ago

Globus Medical Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Globus Medical Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Globus Medical Earnings release: Q1 2025

May 8, 2025, 4:15 PM EDT - 1 year ago

Globus Medical Reports First Quarter 2025 Results

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Globus Medical Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Globus Medical Proxy statement: Proxy Filing

Apr 3, 2025, 8:31 AM EDT - 1 year ago

Globus Medical completes acquisition of Nevro Corp.

Mar 21, 2025, 11:30 AM EDT - 1 year ago

NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO

NVRO

Mar 11, 2025, 4:40 PM EDT - 1 year ago

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

Mar 10, 2025, 7:30 PM EDT - 1 year ago

Globus Medical Transcript: CG 2025 Musculoskeletal Conference

Mar 6, 2025, 4:40 PM EST - 1 year ago

Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting

Mar 5, 2025, 7:01 PM EST - 1 year ago

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Mar 4, 2025, 4:15 PM EST - 1 year ago

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

NVRO

Feb 20, 2025, 4:30 PM EST - 1 year ago

Globus Medical Earnings Call Transcript: Q4 2024

Feb 20, 2025, 4:30 PM EST - 1 year ago

Globus Medical Annual report: Q4 2024

Feb 20, 2025, 4:30 PM EST - 1 year ago

Globus Medical Earnings release: Q4 2024

Feb 20, 2025, 4:15 PM EST - 1 year ago

Globus Medical Reports Fourth Quarter and Full Year 2024 Results

Feb 6, 2025, 12:00 PM EST - 1 year ago

Globus Medical Press release: M&A Announcement

Feb 6, 2025, 9:30 AM EST - 1 year ago

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients

Jan 30, 2025, 4:35 PM EST - 1 year ago

Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

Jan 8, 2025, 12:10 PM EST - 1 year ago

The Law Offices of Frank R. Cruz Continues Its Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors

Dec 16, 2024, 1:32 PM EST - 1 year ago

Four hidden gems in the stock market from a five-star fund manager

CARG PGNY TXRH

IndyOne May. 21 at 6:48 PM

$GMED Nice day, looks like a double top now.

0 · Reply

IndyOne May. 21 at 2:04 PM

$GMED Yes. We got cowbell accumulation.

0 · Reply

LiveTradePro May. 20 at 5:53 PM

$GMED Bottom is in https://share.trendspider.com/chart/GMED/6682ed1lml

1 · Reply

NVDAMillionaire May. 20 at 12:26 AM

0 · Reply

CeaseNDesist May. 19 at 2:19 PM

$GMED green in a sea of red

0 · Reply

IndyOne May. 19 at 10:04 AM

$GMED Needham Raises its Price Target on Globus Medical (GMED) to $117 https://finance.yahoo.com/markets/stocks/articles/needham-raises-price-target-globus-064656298.html

0 · Reply

CapitalMonk May. 12 at 12:10 AM

0 · Reply

MarketBeat May. 10 at 3:12 PM

https://marketbeat.com/a/8646102/ $GMED Globus Medical Q1 Earnings Call Highlights

0 · Reply

StocktwitsEarnings May. 7 at 8:31 PM

0 · Reply

1truth2be3told May. 7 at 8:31 PM

0 · Reply

Estimize May. 7 at 3:00 PM

$GMED reports after the close, Estimize Consensus +0.12 EPS and +27.78M Revs compared to WS http://www.estimize.com/gmed/fq1-2026?utm_conte

0 · Reply

SuperGreenToday Apr. 27 at 4:53 PM

$GMED Share Price: $94.28 Contract Selected: Dec 18, 2026 $95 Calls Buy Zone: $9.61 – $11.87 Target Zone: $17.90 – $21.88 Potential Upside: 76% ROI Time to Expiration: 234 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

G_krupins Apr. 26 at 1:48 PM

$GMED range bound forever. Alert at line if it decides to move

0 · Reply

OnTheGoTrades Apr. 24 at 8:33 PM

$GMED flirting with ATHs

0 · Reply

Doozio Apr. 22 at 3:59 AM

$GMED huckleberries n $$$ patterns as it was always ONTO 🐒🍌🧠⏰♾️

0 · Reply

JFDI Apr. 21 at 9:05 PM

$GMED

0 · Reply

Realtrader77 Apr. 20 at 1:57 PM

$GMED best company to bet on. Robotics / physical AI GROWTH for all musculoskeletal disorders. Well run 3b$ Arr and trades at 12b$ market cap which is cheap. It has close 700m$ cash. Zero debt. Well run and easy take over target. PT 170-200$.

1 · Reply

OfficialStocktwitsUser Apr. 16 at 12:09 AM

$GMED RSI: 69.21, MACD: 1.3905 Vol: 3.27, MA20: 88.52, MA50: 89.03 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Thelonius_Stonk Apr. 14 at 1:51 AM

$GMED 👀

1 · Reply

Armadilloman Mar. 19 at 2:42 PM

$GMED this sad turd being turdy very turdy yet again.

0 · Reply

goldenmanchurian Mar. 17 at 5:33 PM

$ARAY senior management should approach $GEHC $MDT $TMO $GMED to get bought out, for as low as $400MIL., i will vote yes!

0 · Reply

ZacksResearch Mar. 10 at 2:57 PM

5 medical instrument stocks flashing serious short-term upside 👀 $ISRG $GMED $EW $ALC $IRMD are getting attention as AI tools, acquisitions, and new product pipelines fuel growth expectations — a combo that often sparks momentum in this space. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2881459/5-medical-instruments-stocks-to-buy-amid-huge-short-term-price-upside?cid=sm-stocktwits-2-2881459-teaser-36722&ADID=SYND_STOCKTWITS_TWEET_2_2881459_TEASER_36722

0 · Reply

Market Cap	11.19B
Revenue (ttm)	2.94B
Net Income (ttm)	537.87M
EPS (ttm)	N/A
PE Ratio	18.59
Forward PE	17.41
Profit Margin	18.30%
Debt to Equity Ratio	0.00

Volume	1,965,500
Avg Vol	1,434,138
Day's Range	N/A - N/A
Shares Out	135.75M
Stochastic %K	56%
Beta	1.00
Analysts	Strong Sell
Price Target	$111.08